254 related articles for article (PubMed ID: 20034955)
1. The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization.
Sealey DC; Zheng L; Taboski MA; Cruickshank J; Ikura M; Harrington LA
Nucleic Acids Res; 2010 Apr; 38(6):2019-35. PubMed ID: 20034955
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo.
Wyatt HD; Tsang AR; Lobb DA; Beattie TL
PLoS One; 2009 Sep; 4(9):e7176. PubMed ID: 19777057
[TBL] [Abstract][Full Text] [Related]
3. Putative telomere-recruiting domain in the catalytic subunit of human telomerase.
Armbruster BN; Etheridge KT; Broccoli D; Counter CM
Mol Cell Biol; 2003 May; 23(9):3237-46. PubMed ID: 12697823
[TBL] [Abstract][Full Text] [Related]
4. Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1.
Armbruster BN; Linardic CM; Veldman T; Bansal NP; Downie DL; Counter CM
Mol Cell Biol; 2004 Apr; 24(8):3552-61. PubMed ID: 15060173
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cellular immortalization and steady-state levels of the telomerase reverse transcriptase through its carboxy-terminal domain.
Middleman EJ; Choi J; Venteicher AS; Cheung P; Artandi SE
Mol Cell Biol; 2006 Mar; 26(6):2146-59. PubMed ID: 16507993
[TBL] [Abstract][Full Text] [Related]
6. The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.
Huard S; Moriarty TJ; Autexier C
Nucleic Acids Res; 2003 Jul; 31(14):4059-70. PubMed ID: 12853623
[TBL] [Abstract][Full Text] [Related]
7. A translocation-defective telomerase with low levels of activity and processivity stabilizes short telomeres and confers immortalization.
D'Souza Y; Chu TW; Autexier C
Mol Biol Cell; 2013 May; 24(9):1469-79. PubMed ID: 23447707
[TBL] [Abstract][Full Text] [Related]
8. Complex interaction network revealed by mutation of human telomerase 'insertion in fingers' and essential N-terminal domains and the telomere protein TPP1.
Lambert-Lanteigne P; Young A; Autexier C
J Biol Chem; 2023 Mar; 299(3):102916. PubMed ID: 36649908
[TBL] [Abstract][Full Text] [Related]
9. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.
Moriarty TJ; Ward RJ; Taboski MA; Autexier C
Mol Biol Cell; 2005 Jul; 16(7):3152-61. PubMed ID: 15857955
[TBL] [Abstract][Full Text] [Related]
10. Characterization of physical and functional anchor site interactions in human telomerase.
Wyatt HD; Lobb DA; Beattie TL
Mol Cell Biol; 2007 Apr; 27(8):3226-40. PubMed ID: 17296728
[TBL] [Abstract][Full Text] [Related]
11. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.
Colgin LM; Wilkinson C; Englezou A; Kilian A; Robinson MO; Reddel RR
Neoplasia; 2000; 2(5):426-32. PubMed ID: 11191109
[TBL] [Abstract][Full Text] [Related]
12. Catalytically active human telomerase mutants with allele-specific biological properties.
Kim M; Xu L; Blackburn EH
Exp Cell Res; 2003 Aug; 288(2):277-87. PubMed ID: 12915119
[TBL] [Abstract][Full Text] [Related]
13. Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit.
Moriarty TJ; Huard S; Dupuis S; Autexier C
Mol Cell Biol; 2002 Feb; 22(4):1253-65. PubMed ID: 11809815
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity does not always imply telomere maintenance.
Ouellette MM; Aisner DL; Savre-Train I; Wright WE; Shay JW
Biochem Biophys Res Commun; 1999 Jan; 254(3):795-803. PubMed ID: 9920820
[TBL] [Abstract][Full Text] [Related]
15. A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation.
Marie-Egyptienne DT; Cerone MA; Londoño-Vallejo JA; Autexier C
Nucleic Acids Res; 2005; 33(17):5446-57. PubMed ID: 16192571
[TBL] [Abstract][Full Text] [Related]
16. Direct observation of nucleic acid binding dynamics by the telomerase essential N-terminal domain.
Shastry S; Steinberg-Neifach O; Lue N; Stone MD
Nucleic Acids Res; 2018 Apr; 46(6):3088-3102. PubMed ID: 29474579
[TBL] [Abstract][Full Text] [Related]
17. Telomeres, telomerase, and myc. An update.
Cerni C
Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922
[TBL] [Abstract][Full Text] [Related]
18. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
19. Regulation of telomere length by an N-terminal region of the yeast telomerase reverse transcriptase.
Ji H; Platts MH; Dharamsi LM; Friedman KL
Mol Cell Biol; 2005 Oct; 25(20):9103-14. PubMed ID: 16199886
[TBL] [Abstract][Full Text] [Related]
20. Human Ku70/80 associates physically with telomerase through interaction with hTERT.
Chai W; Ford LP; Lenertz L; Wright WE; Shay JW
J Biol Chem; 2002 Dec; 277(49):47242-7. PubMed ID: 12377759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
